glp-1 and satiety Reflections on the discovery as a hormone: Implications for obesity therapy future directions Glucagon-Like Peptide-1: New Regulator in

Canberra: Office of the Gene Technology Regulator, Department of Health and Ageing, Australian Government (2008)

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses

Chemicals from plastics, fragrances, cleaners, and personal-care products can place additional load on metabolism, hormones, and immune balance

Avoid leaving the cream in a hot car or in direct sun while traveling

People who are taking these new weight loss drugs, he posited, may then find themselves compelled to further limit how much food they eat, even when it endangers their health